首页> 外文期刊>Journal of Medicinal Chemistry >Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13)
【24h】

Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13)

机译:神经狭窄术(8-13)有效镇痛大规模类似物的结构优化与表征

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The neurotensin receptors are attractive targets for the development of new analgesic compounds. They represent potential alternatives or adjuvants to opioids. Herein, we report the structural optimization of our recently reported macrocyclic peptide analogues of NT(8-13). The macrocycle was formed via ring-closing metathesis (RCM) between an ortho allylated tyrosine residue in position 11 and the side chain of alkene-functionalized amino acid in position 8 of NT(8-13). Minute modifications led to significant binding affinity improvement (K-i improved from 5600 to 15 nM) with greatly improved plasma stability compared to NT(8-13). This study also delineates the structural features influencing these parameters. The signaling profiles of the new macrocycles were determined on the NTS1 receptor, and the physiological effects of the two most potent and stable analogues were assessed in vivo using rodent models. Both compounds displayed strong analgesic effects.
机译:神经调节素受体是用于开发新的镇痛化合物的靶标。 它们代表潜在的替代品或佐剂给阿片类药物。 在此,我们报告了我们最近报告的NT(8-13)的宏环肽类似物的结构优化。 通过在NT(8-13)的位置11中的邻烯醇化酪氨酸残基之间的邻烯醇化酪氨酸残基与烯烃官能化氨基酸的侧链之间通过闭环复分解(RCM)形成宏循环。 微小的修饰导致显着的结合亲和力改善(K-I从5600至15nm提升),与NT(8-13)相比,具有大大提高的等离子体稳定性。 本研究还描绘了影响这些参数的结构特征。 在NTS1受体上测定新的宏蜂鸣的信号传导型,并且使用啮齿动物模型在体内进行两种最有效和稳定的类似物的生理效果。 两种化合物都显示出强烈的镇痛作用。

著录项

  • 来源
    《Journal of Medicinal Chemistry》 |2018年第16期|共13页
  • 作者单位

    Univ Sherbrooke Inst Pharmacol Sherbrooke Fac Med &

    Hlth Sci Dept Pharmacol &

    Physiol 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

    Univ Sherbrooke Inst Pharmacol Sherbrooke Fac Med &

    Hlth Sci Dept Pharmacol &

    Physiol 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

    Univ Sherbrooke Inst Pharmacol Sherbrooke Fac Med &

    Hlth Sci Dept Pharmacol &

    Physiol 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

    Univ Sherbrooke Inst Pharmacol Sherbrooke Fac Med &

    Hlth Sci Dept Pharmacol &

    Physiol 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

    Univ Sherbrooke Inst Pharmacol Sherbrooke Fac Med &

    Hlth Sci Dept Pharmacol &

    Physiol 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

    Univ Sherbrooke Inst Pharmacol Sherbrooke Fac Med &

    Hlth Sci Dept Pharmacol &

    Physiol 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

    Univ Sherbrooke Inst Pharmacol Sherbrooke Fac Med &

    Hlth Sci Dept Pharmacol &

    Physiol 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

    Univ Sherbrooke Inst Pharmacol Sherbrooke Fac Med &

    Hlth Sci Dept Pharmacol &

    Physiol 3001 12e Ave Nord Sherbrooke PQ J1H 5N4 Canada;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号